Griffith B Perkins
Overview
Explore the profile of Griffith B Perkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Asare P, Hurtado P, Tran H, Perkins G, Roscioli E, Hodge S
Clin Exp Med
. 2023 Jun;
23(7):4041-4055.
PMID: 37310658
Background: A common feature of COPD is a defective lung macrophage phagocytic capacity that can contribute to chronic lung inflammation and infection. The precise mechanisms remain incompletely understood, although cigarette...
12.
Zhang W, Kedzierski L, Chua B, Mayo M, Lonzi C, Rigas V, et al.
Nat Immunol
. 2023 May;
24(6):966-978.
PMID: 37248417
High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies,...
13.
Alcheikh A, Perkins G, Pucar P, Cecchin A, Chai C, Tunbridge M, et al.
Blood Cancer J
. 2023 Apr;
13(1):50.
PMID: 37032391
No abstract available.
14.
Perkins G, Grey S, Coates P
Kidney Int
. 2023 Jan;
103(2):246-248.
PMID: 36681450
No abstract available.
15.
Singer J, Tunbridge M, Perkins G, Salehi T, Ying T, Wu H, et al.
BMJ Open
. 2022 Dec;
12(12):e062747.
PMID: 36456021
Introduction: Kidney transplant recipients (KTRs) are at an increased risk of hospitalisation and death from COVID-19. Vaccination against SARS-CoV-2 is our primary risk mitigation strategy, yet vaccine effectiveness in KTRs...
16.
Perkins G, Hurtado P, Hissaria P
Allergy
. 2022 Nov;
77(12):3704-3705.
PMID: 36441594
No abstract available.
17.
Tunbridge M, Perkins G, Singer J, Salehi T, Ying T, Grubor-Bauk B, et al.
Trials
. 2022 Sep;
23(1):780.
PMID: 36109788
Methods: RIVASTIM-rapamycin is a multicentre, randomised, controlled trial examining the effect of immunosuppression modification prior to a third dose of COVID-19 vaccine in kidney transplant recipients who have failed to...
18.
Perkins G, Tunbridge M, Salehi T, Chai C, Kireta S, Johnston J, et al.
Kidney Int
. 2022 Mar;
101(5):1077-1080.
PMID: 35304094
No abstract available.
19.
Asare P, Tran H, Hurtado P, Perkins G, Nguyen P, Jersmann H, et al.
Ther Adv Respir Dis
. 2021 Dec;
15:17534666211039769.
PMID: 34852704
Introduction/rationale: In chronic obstructive pulmonary disease (COPD), defective macrophage phagocytic clearance of cells undergoing apoptosis by efferocytosis may lead to secondary necrosis of the uncleared cells and contribute to airway...
20.
Zidan A, Perkins G, Al-Hawwas M, Elhossiny A, Yang J, Bobrovskaya L, et al.
Stem Cells
. 2021 Feb;
39(6):803-818.
PMID: 33554422
The interplay between mesenchymal stem cells (MSCs) and immune cells has been studied for MSCs isolated from different tissues. However, the immunomodulatory capacity of urine stem cells (USCs) has not...